DarioHealth Corp. reported its financial results for the second quarter of 2025, revealing total revenues of $5.37 million, a decrease of 14.2% from $6.26 million in the same period last year. For the first half of 2025, revenues slightly increased to $12.12 million from $12.01 million in the prior year. The company experienced a net loss of $12.99 million for the quarter, compared to a loss of $13.61 million in Q2 2024. The net loss attributable to common shareholders for the first half of 2025 was $32.63 million, up from $14.11 million in the same period last year.
The company’s operational metrics showed a decline in service revenues, which fell to $3.66 million from $4.66 million year-over-year. Consumer hardware revenues, however, increased to $1.71 million from $1.60 million. DarioHealth's gross profit for the second quarter was $2.96 million, up from $2.76 million in the previous year, indicating improved cost management despite the revenue decline. Total operating expenses decreased significantly to $12.16 million from $18.95 million, reflecting the company's efforts to streamline operations.
DarioHealth has made strategic advancements, including the acquisition of Twill, Inc. in February 2024, which is expected to enhance its digital therapeutic offerings. The company continues to focus on expanding its market presence and product adoption, particularly in the digital health sector. As of June 30, 2025, DarioHealth reported a total of 45.47 million shares outstanding, an increase from 38.39 million shares at the end of 2024, reflecting ongoing capital-raising efforts.
The company’s cash and cash equivalents stood at $21.95 million as of June 30, 2025, down from $27.76 million at the end of 2024. DarioHealth has indicated that it expects to continue incurring losses and negative cash flows, with an accumulated deficit of $422.97 million. The company is actively seeking additional funding to support its operations and product development initiatives. Looking ahead, DarioHealth anticipates that its transition to profitability will depend on the successful commercialization of its products and achieving sufficient revenue levels to cover operational costs.
About DarioHealth Corp.
DarioHealth is a global digital health company specializing in whole-person health management. It offers personalized digital therapeutics and virtual care solutions across physical, mental, and behavioral health conditions. Serving employers, health plans, pharmaceutical companies, and consumers, it leverages AI, data analytics, and engaging user experiences to deliver improved clinical outcomes, cost savings, and high ROI through integrated, scalable platforms focused on chronic disease, mental health, and preventive care.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.